This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. advanced 5.9% to $8.74 on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 0.2% to 25,297.62 and Dow Jones Industrial Average falling 0.1% to 51,876.11.
This was the stock's second consecutive day of gains.
Corbus Pharmaceuticals Holdings Inc. closed 57.5% short of its 52-week high of $20.56, which the company reached on October 20th.
The stock outperformed some of its peers, as Vanda Pharmaceuticals Inc. rose 2.7% to $6.01, Fortress Biotech Inc. fell 8.6% to $2.76, and Viking Therapeutics Inc. rose 2.84% to $38.04.
Trading volume totaled 2.4 million, compared to the 50-day average of 489,238.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
June 26, 2026 16:35 ET (20:35 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments